Factor XIII Val34Leu mutation accelerates the development of fibrosis in patients with chronic hepatitis B and C
スポンサーリンク
概要
- 論文の詳細を見る
- 2012-07-01
著者
-
Reesink Henk
Department Of Hepatology Academic Medical Center
-
Levi Marcel
Department Of Internal Medicine Academic Medical Center University Of Amsterdam
-
BART TAKKENBERG
Department of Gastroenterology and Hepatology, Academic Medical Center, University of Amsterdam
-
DIK Kathelijne
Department of Internal Medicine, Academic Medical Center, University of Amsterdam
-
DE BRUIJNE
Department of Gastroenterology and Hepatology, Academic Medical Center, University of Amsterdam
-
ROELOFS Joris
Department of Pathology, Academic Medical Center, University of Amsterdam
-
TEMPELMANS Marjan
Department of Experimental Immunology, Academic Medical Center, University of Amsterdam
-
DIJKGRAAF Marcel
Clinical Research Unit, Academic Medical Center, University of Amsterdam
-
GELDERBLOM Huub
Department of Paediatrics, University of Oxford
-
MEIJERS Joost
Department of Vascular Medicine, Academic Medical Center, University of Amsterdam
-
JANSEN Peter
Department of Gastroenterology and Hepatology, Academic Medical Center, University of Amsterdam
関連論文
- Cholestasis enhances liver ischemia/reperfusion-induced coagulation activation in rats
- Development of myasthenia gravis during treatment of chronic hepatitis C with interferon-alpha and ribavirin
- Experimental and clinical research on the interaction between inflammation and coagulation and its control by natural anticoagulants
- A Role of Activated Protein C in SIRS, Sepsis and MODS
- Factor XIII Val34Leu mutation accelerates the development of fibrosis in patients with chronic hepatitis B and C